February 18th 2021 at 6.00 pm CET
Telemedicine & The Patient Experience
DALE C. VAN DEMARK
McDermott Will & Emery LLP
During this program we will review the regulatory environment for telemedicine and prospects for more rapid adoption in light of responses to the COVID-19 pandemic. During the course of the program we will review the traditional areas of regulatory stress for telemedicine programs, the nature of government regulation and the underlying policies governing the regulatory framework. Finally, we will review telemedicine regulation liberalization in response to COVID-19 and what it might mean for more permanent liberalization for virtual care solutions.
About the speaker
With robust experience in health system affiliations, joint venture transactions, cross-industry collaborations and development of new healthcare delivery models, Dale C. Van Demark works at the forefront of strategic transactions and digital health in the health, life sciences and technology industries. A sought-after legal, strategic and policy advisor, he’s well-informed on integrating information technology into healthcare and has worked on numerous care delivery, life sciences research and development, and artificial intelligence matters.
Dale advises international clients on entering the US healthcare market and works closely with McDermott’s European offices to offer strategic guidance to US-based clients looking to break into new markets.
• Served as lead transaction counsel for a top health system in a collaboration arrangement with a prominent life sciences firm that enabled sharing health data for research and development to improve health system laboratory functions.
• Led a team to assist a health system in acquiring a financially distressed municipal hospital.
• Advised a leading health system in establishing telemedicine-based health programs in Asia and South America.
• Assisted in developing white papers and guiding principles for virtual care and related subjects alongside a noted trade association.
Additionally, Dale serves on the Children’s Health Fund’s advisory council.
December 17th 2020 at 6.00 pm CET Innovations & Standards: Conflict or Convergence? Dr. Claudia MikaFounder and CEO of Temos International Healthcare Accreditation Daniel C. ShawAmbassador for the Global Clinic Rating Accreditation in healthcare, which should...
November 5th 2020 at 6.00 pm CET Marketing Healthcare Innovations Mario Ravić, M.Sc.E.E, CPHIMSHead of IoT & Digital HealthEricsson NikolaTesla d.d. Marc Ortmans, CEO, Creative DirectorMarc Ortmans Brand Communications, Chair, GEN UK Ericsson Nikola Tesla has over...
October 15th 2020 at 6.00 pm CEST Patient Experience During and After COVID-19 Pandemic Rahul Kashyap, MBBS, MBAAssistant Professor, Mayo ClinicLead Investigator, VIRUS: COVID-19 Registry https://sccmcovid19.org/ The COVID-19 pandemic has changed the world and...
September 10th at 6.00 pm CEST Innovations in the Patient Experience Digitisation Enhancing Innovations in Patient Care & Experience Getting the best possible outcomes for patients efficiently, effectively, with care and safety is your number one priority. With...
August 27th at 6.00 pm CEST The Patient Journey & Innovation We often look to other industries for clues to improve our own practices. This is why we invited tourism expert Doug Lansky to provide some insight into customer service and how it can...
July 9th at 2020 at 1:00 PM EDT / 6:00 PM CET The Patient Experience & Outcome Measures Chris Graham and Karin Jay Restoring Consumer Confidence by Partnering with Patients and Families Karin Jay The outbreak of COVID-19 resulted in widespread restrictions in...
June 18th at 6:00 p.m. CET New Markets, New Patient Expectations Irving Stackpole & Elizabeth Ziemba Before the global SARS-CoV-2 pandemic, healthcare innovations were being driven by underlying dynamics of change: the need for greater efficiencies, profit...